Gujarat Terce Laboratories Limited · BSE:GUJTERC

Gujarat Terce Laboratories — Q2 FY25 Earnings Presentation

9 slides from Gujarat Terce Laboratories's earnings presentation, Oct 28, 2024

  1. Slide 1: Investor Presentation Cover Letter to BSE

    GUJARAT F£ifCS LABORATORJ£S LJIMJYED Date: 28-10-2024 To, Scrip Code: 524314 BSE Limited Security ID: GUJTERC Corporate Relation Department ISIN: INE499G01013 PhirozeJeejeebhoy Towers, Dalai Streets, Mumbai- 400001, Maharashtra, India Dear Sir/Madam, Sub: Investors Presentation for Quarter and half

  2. Slide 2: Q2 FY25 Financial Results & Business Update

    GUJARAT TERCE LABORATORIES LIMITED Q2 Q2 FY25 FY25|| FINANCIAL FINANCIAL RESULTS RESULTS&& BUSINESS BUSINESS UPDATE UPDATE

  3. Slide 3: Safe Harbour

    SAFE HARBOUR THIS PRESENTATION CONTAINS CERTAIN FORWARD-LOOKING STATEMENTS CONCERNING OUR OUR FUTURE BUSINESS AND PROSPECTS AND BUSINESS PROFITABILITY, WHICH ARE ARE SUBJECT TO TO SEVERAL RISKS AND UNCERTAINTIES & THE AND UNCERTAINTIES& THE ACTUAL RESULTS COULD MATERIALLY DIFFER FROM THOSE IN SUCH F

  4. Slide 4: Performance Highlights

    PERFORMANCE HIGHLIGHTS âk s rr REVENUE REVENUE EBIDTA EBIDTA NET NET PROFIT PROFIT PCPM PCPM Q2/FY24 Q2/FY25 Q2/FY24 Q2/FY25 Q2/FY24 Q2/FY25 Q2/FY24 Q2/FY25 [1203.03] [1203.03] [1330.12] [1330.12] [62.58] [62.58] [174.21] [174.21] [33.47] [33.47] [148.22] [148.22] [1.75] [2.75] [10.5]% [178]% [343]%

  5. Slide 5: Profit & Loss Summary

    PROFIT PROFIT&& LOSS LOSS SUMMARY SUMMARY (INR Lakh) Particulars Q2 FY25 Q2 FY24 Change % H1 FY25 H1 FY24 Change % 2023-24 Revenue Revenue 1330.12 1203.03 10.56 10.56%% 2519.00 2274.74 10.74 10.74%% 4797.47 EBITDA 174.21 62.58 178 178%% 189.34 (42.53) 545 545 %% 158.7 Cash Profit 157.66 42.59 270 27

  6. Slide 6: Management Commentary

    MANAGEMENT COMMENTARY DEAR II am am delighted to report that our business has delivered deliveredaa 10.56%% YoY YoY growth in We We remain remain Q2/ Q2/ FY25 compared tothesame to the same period in the the previous year. Our SHAREHOLDERS, on on transforming the business is yielding the the desired

  7. Slide 7: Brand Highlights

    ‫ש‬ Q2 FY25 | FINANCIAL RESULTS & BUSINESS UPDATE )> ‫ם‬ "'5 ‫ב‬ Q.? )‫מ‬ 1/( ‫פר‬ E?? ‫גם‬ Z? 38 Q2/FY25 ?‫ו‬ (Rs in Lakh) 82 SZAzl/ZD .115-::: ‫כ‬ ED? 025 Growth: 58.33% U')? %88'85 “HMO-'9 ‫בט‬ U1? 2-“ .‘3 24 172 Q2/FY24 ??‫מן‬/?0 ‫נע‬ II? _A? :) U? Z? )> I-? Z? E? ‫ו‬.‫ח‬ N?-< H.? N? d? ‫ם‬ .‫גס

  8. Slide 8: Marketing Activities

    MARKETING ACTIVITIES MARKETING ACTIVITIES RAKSHA BANDHAN INDEPENDENCE DAY PHARMACISTS DAY (Click on the above images to go to our Facebook page) (Click on the above images to go to our Facebook page) GUJARAT TERCE LABORATORIES LIMITED 07 Q2 Q2 FY25 FY25| | FINANCIAL FINANCIAL RESULTS RESULTS&& BUSIN

  9. Slide 9: Thank You

    THE COMPANY ABOUT THECOMPANY Gujarat Terce has over three decades of of experience in manufacturing and and marketing branded generics to provide the general public with accessible healthcare. The roots of Gujarat Terce Laboratories Limited are entrenched in the The the founding principles of... COM

Gujarat Terce Laboratories — Q2 FY25 Earnings Presentation on 6ix